Curve Biosciences: Valuation, Funding & Investors
Curve Biosciences is the Whole-Body Intelligence company. Curve has created the first molecular blueprint of the human body by manually curating the world's largest collection of comprehensively-characterized tissue samples into its Whole-Body Atlas. Trained on the clarity of this atlas, the company's Whole-Body Intelligence models identify chronic disease states through its Whole-Body Blood Tests earlier and more accurately than other methods. Curve's mission is to provide doctors the best intelligence for their patients and to alleviate the pain of chronic diseases by anchoring medicine in biological truth.
Leadership & Board
- Current Number of Employees
- 25
- Current LinkedIn Followers
- 7,919
Latest Estimated Valuation
- Total Amount Raised
- $40M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $40M
- Latest Funding Round
- Investment
Employee Trend
Curve Biosciences had 25 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Curve Biosciences had 7,919 followers as of November 2, 2026. The number of followers increased by 16 (0.20%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 29, 2025 | Investment | $40.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| First Spark Ventures | Investment |
| LifeX Ventures | Investment |
| NZVC | Investment |
| Luma Group | Investment |
| Techas Capital | Investment |
| Micah Spear | Investment |
| Civilization Ventures | Investment |
| Incite | Investment |
Similar Companies
A snapshot of private companies similar to Curve Biosciences, helping you discover and navigate related company profiles.
